Posted by Michael Wonder on 23 Jul 2019
EMA publishes agenda for 22-25 July CHMP meeting
22 July 2019 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue initial opinions for the following technologies:
- Deferasirox
- Cannabidiol
- Levodopa
- Polatuzumab vedotin
- Lignocaine with prilocaine
- Ibalizumab
- Larotrectinib
